A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mansoor Raza Mirza; Bente Lund; Jacob Christian Lindegaard; Nina Keldsen; Anders Mellemgaard; René dePont Christensen; Kamma Bertelsen

doi:10.1016/j.ygyno.2010.06.022

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mansoor Raza Mirza, Bente Lund, Jacob Christian Lindegaard, Nina Keldsen, Anders Mellemgaard, René dePont Christensen, Kamma Bertelsen

Institut for Klinisk Medicin

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

11 Citationer (Scopus)

Abstract

Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.

Originalsprog	Engelsk
Tidsskrift	Journal of Gynecologic Oncology Nursing
Vol/bind	119
Udgave nummer	1
Sider (fra-til)	26-31
Antal sider	6
ISSN	1536-9935
DOI	https://doi.org/10.1016/j.ygyno.2010.06.022
Status	Udgivet - 1 okt. 2010

Adgang til dokumentet

10.1016/j.ygyno.2010.06.022

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin. / Mirza, Mansoor Raza; Lund, Bente; Lindegaard, Jacob Christian et al.
I: Journal of Gynecologic Oncology Nursing, Bind 119, Nr. 1, 01.10.2010, s. 26-31.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{2548542771c44cd09e68bf65640583eb,

title = "A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin",

abstract = "Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.",

author = "Mirza, {Mansoor Raza} and Bente Lund and Lindegaard, {Jacob Christian} and Nina Keldsen and Anders Mellemgaard and Christensen, {Ren{\'e} dePont} and Kamma Bertelsen",

year = "2010",

month = oct,

day = "1",

doi = "10.1016/j.ygyno.2010.06.022",

language = "English",

volume = "119",

pages = "26--31",

journal = "Journal of Gynecologic Oncology Nursing",

issn = "1536-9935",

publisher = "Society of Gynecologic Nurse Oncologists",

number = "1",

}

TY - JOUR

T1 - A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

AU - Mirza, Mansoor Raza

AU - Lund, Bente

AU - Lindegaard, Jacob Christian

AU - Keldsen, Nina

AU - Mellemgaard, Anders

AU - Christensen, René dePont

AU - Bertelsen, Kamma

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.

AB - Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.

U2 - 10.1016/j.ygyno.2010.06.022

DO - 10.1016/j.ygyno.2010.06.022

M3 - Journal article

SN - 1536-9935

VL - 119

SP - 26

EP - 31

JO - Journal of Gynecologic Oncology Nursing

JF - Journal of Gynecologic Oncology Nursing

IS - 1

ER -